Entera Bio Ltd reports results for the quarter ended in March - Earnings Summary

Entera Bio

10/05/2024 22:59

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss of 5
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -8
cents.  The lone analyst forecast for the quarter was for a loss
of 6 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 5
cents​.
    * The company reported a quarterly loss of $2.02 million.
    * Entera Bio Ltd shares had risen by 52.1% this quarter and
gained 323.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 50% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Entera Bio Ltd is
$10.00 
This summary was machine generated from LSEG data May 10 at
09:58 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.06          -0.05          Beat
 Dec. 31 2023      -0.08          -0.07          Beat
 Sep. 30 2023      -0.09          -0.08          Beat
 Jun. 30 2023      -0.07          -0.08          Missed